8 Top Gastroenterology News to Know

Two FDA approvals for chronic constipation treatments, a pair of new clinical guidelines from the ACG, and the widely covered report calling for reclassification of the mesentery as a single continuous organ ranked among the most popular gastroenterology topics covered on Healio.com in January.

Below, the editors of Healio Gastroenterology have compiled January’s top 8 gastroenterology articles.

Specific carbohydrate diet shows promise in pediatric IBD

Children with Crohn’s disease and ulcerative colitis achieved clinical remission after specific carbohydrate diet therapy, according to the results of a small prospective study. Read more

FDA approves new treatment for chronic constipation

Trulance received FDA approval for the treatment of chronic idiopathic constipation, according to press releases from the manufacturer and the FDA. Read more

ACG issues new guidelines for preventive care in IBD patients

A new clinical guideline released by the ACG highlights the importance of preventive care in patients with inflammatory bowel disease, and recommends co-management of health maintenance issues by gastroenterologists, primary care providers and other specialists. Read more

ACG guideline expands indications for H. pylori testing, treatment

The ACG has released new, updated guideline recommendations on the treatment of Helicobacter pylori infection in North America, based on the latest international data and expert consensus. Read more

Mesentery reclassified as single, continuous organ

The mesentery, long considered to be a fragmented and complex structure connecting the intestine to the abdomen, has been reclassified as a single, continuous organ by researchers at the University of Limerick, Ireland, prompting the latest edition of Gray’s Anatomy to adopt this view. Read more

Red meat linked to diverticulitis risk

Researchers linked red meat consumption – especially when unprocessed – with a heightened risk for diverticulitis in an observational study. Read more

FDA issues draft guidance on biosimilar interchangeability

The FDA has released a draft guidance for industry outlining criteria for demonstrating that a biosimilar is interchangeable with a reference product under section 351 (k) of the Public Health Service Act. Read more

FDA approves lower dose Linzess for chronic idiopathic constipation

The FDA has approved a 72-µg dose of Linzess for adults with chronic idiopathic constipation, which Ironwood and Allergan expect to be available in the first quarter of 2017, the companies announced. Read more